Moderated Discussion – Outlining Methods to Improve the Quality of Life for HFpEF Patients

Time: 2:15 pm
day: Day Two


  • What has been observed in previous trials with respect to mortality rates and what have interim analyses shown?
  • What steps have been taken to improve this definition for HFpEF patient?
  • How does changing the definition for quality of life subsequently alter the drug development industry?